[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338107-105":59,"doc-detail-338107-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","is-there-a-link-between-chronic-obstructive-pulmonary-disease-and-lung-adenocarcinoma-clinico-pathological-and-molecular-study","Is There a Link between Chronic Obstructive Pulmonary Disease and Lung Adenocarcinoma? - Clinico-Pathological and Molecular Study","","Chronic obstructive pulmonary disease (COPD) and lung cancer are closely related, yet it remains unclear whether COPD-associated tumors differ from lung adenocarcinoma in non-COPD patients. This clinico-pathological and molecular study compared morphological and molecular profiles of lung adenocarcinoma among COPD/smokers, non-COPD/smokers, and non-COPD/non-smokers, including analyses of genetically unstable non-neoplastic areas. Ninety-eight sequenced samples were evaluated with a 30-gene NGS panel, revealing group-specific proliferative, histologic, and mutation patterns, and supporting screening implications.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/is-there-a-link-between-chronic-obstructive-pulmonary-disease-and-lung-adenocarcinoma-clinico-pathological-and-molecular-study/338107/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/is-there-a-link-between-chronic-obstructive-pulmonary-disease-and-lung-adenocarcinoma-clinico-pathological-and-molecular-study/338107.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main objective of the study?","Question",{"text":113,"@type":114},"To compare morphological and molecular profiles of lung adenocarcinoma across COPD and non-COPD groups, and to determine whether genetic instability also appears in non-neoplastic areas.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were patients grouped for analysis?",{"text":118,"@type":114},"The study included 110 patients undergoing surgery for LUAD, divided into three groups: COPD/smoker LUAD, non-COPD/smoker LUAD, and non-COPD/non-smoker LUAD.",{"name":120,"@type":111,"acceptedAnswer":121},"What genetic and molecular findings were reported across the groups?",{"text":122,"@type":114},"Non-COPD/smoker LUAD showed higher proliferative index, while non-COPD/non-smoker LUAD had higher lepidic pattern percentages, lower necrosis, higher fibrosis, and a lower mutation rate in KRAS and PIK3CA. The same gene mutations were detected in both pathological and normal areas in COPD/smokers and non-COPD/smokers.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338107,1790450718,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article  \nIs There a Link between Chronic Obstructive Pulmonary Disease and Lung Adenocarcinoma? A Clinico-Pathological and Molecular Study  \nFrancesca Lunardi 1,†, Giorgia Nardo 2,†, Elisabetta Lazzarini 2, Soﬁa-Eleni Tzorakoleftheraki 3, Giovanni Maria Comacchio 1, Eugenio Fonzi 4, Michela Tebaldi 4, Luca Vedovelli 1, Federica Pezzuto 1, Francesco Fortarezza 1, Marco Schiavon 1, Federico Rea 1, Stefano Indraccolo 2,5 and Fiorella Calabrese 1, *  \nCitation: Lunardi, F.; Nardo, G.; Lazzarini, E.; Tzorakoleftheraki, S.-E.; Comacchio, G.M.; Fonzi, E.; Tebaldi, M.; Vedovelli, L.; Pezzuto, F.; Fortarezza, F.; et al. Is There a Link between Chronic Obstructive Pulmonary Disease and Lung Adenocarcinoma? A  \nClinico-Pathological and Molecular Study. J. Pers. Med. 2024, 14, 839 . [https://doi.org/10.3390/jpm14080839](https://doi.org/10.3390/jpm14080839)  \nAcademic Editor: Andrea Ambrosini-Spaltro  \nReceived: 24 June 2024  \nRevised: 3 August 2024  \nAccepted: 6 August 2024  \nPublished: 8 August 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova,  \n35128 Padova, Italy; [francesca.lunardi@unipd.it](francesca.lunardi@unipd.it) (F.L.); [giovannimaria.comacchio@aopd.veneto.it](giovannimaria.comacchio@aopd.veneto.it) (G.M.C.); [luca.vedovelli@ubep.unipd.it](luca.vedovelli@ubep.unipd.it) (L.V.); [federica.pezzuto@unipd.it](federica.pezzuto@unipd.it) (F.P.);  \n[francesco.fortarezza@aopd.veneto.it](francesco.fortarezza@aopd.veneto.it) (F.F.); [marco.schiavon@unipd.it](marco.schiavon@unipd.it) (M.S.); [federico.rea@unipd.it](federico.rea@unipd.it) (F.R.)  \n2 Basic and Translational Oncology Unit, Istituto Oncologico Veneto IOV—IRCCS, 35128 Padova, Italy; [giorgia.nardo@iov.veneto.it](giorgia.nardo@iov.veneto.it) (G.N.); [elisabetta.lazzarini@iov.veneto.it](elisabetta.lazzarini@iov.veneto.it) (E.L.); [stefano.indraccolo@unipd.it](stefano.indraccolo@unipd.it) (S.I.)  \n3 Department of Pathology, Aristotle University of Thessaloniki, GR-54124 Thessaloniki, Greece; [stzorako@auth.gr](stzorako@auth.gr)  \n4 IRCCS Istituto Tumori “Dino Amadori” IRST, 47014 Meldola, Italy; [eugenio.fonzi@irst.emr.it](eugenio.fonzi@irst.emr.it) (E.F.); [michela.tebaldi@irst.emr.it](michela.tebaldi@irst.emr.it) (M.T.)  \n5 Department of Surgery Oncology and Gastroenterology, University of Padova, 35124 Padova, Italy  \n* Correspondence: ﬁ[orella.calabrese@unipd.it](orella.calabrese@unipd.it)[ ](orella.calabrese@unipd.it)† These authors equally contributed to the study.  \nAbstract: Chronic Obstructive Pulmonary Disease (COPD) and lung cancer are strictly related. To date, it is unknown if COPD-associated cancers are different from the tumors of non-COPD patients. The main goal of the study was to compare the morphological/molecular proﬁles of lung adenocarcinoma (LUAD) samples of COPD, non-COPD/smokers and non-COPD/non-smokers, and to investigate if a genetic instability also characterized non-pathological areas. This study included 110 patients undergoing surgery for a LUAD, divided into three groups: COPD/smoker LUAD (38), non-COPD/smoker LUAD (54) and non-COPD/non-smoker LUAD (18) . The tissue samples were systemically evaluated by pathologists and analyzed using a 30-gene Next Generation Sequencing (NGS) panel. In a subset of patients, tissues taken far from the neoplasia were also included. The non-COPD/smoker LUAD were characterized by a higher proliferative index (p = 0.001), while the non-COPD/non-smoker LUAD showed higher percentages of lepidic pattern (p = 0.008), lower necrosis, higher ﬁbrosis, and a signiﬁcantly lower mutation rate in the KRAS and PIK3CA genes. In","cbCaigAr6LtdVdto","https://ap.wps.com/l/cbCaigAr6LtdVdto","pdf",2252218,14,"English","# Abstract\n# Introduction\n# Materials and Methods\n# Results\n# Discussion\n# Conclusions","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To compare morphological and molecular profiles of lung adenocarcinoma across COPD and non-COPD groups, and to determine whether genetic instability also appears in non-neoplastic areas.\"},{\"question\":\"How were patients grouped for analysis?\",\"answer\":\"The study included 110 patients undergoing surgery for LUAD, divided into three groups: COPD/smoker LUAD, non-COPD/smoker LUAD, and non-COPD/non-smoker LUAD.\"},{\"question\":\"What genetic and molecular findings were reported across the groups?\",\"answer\":\"Non-COPD/smoker LUAD showed higher proliferative index, while non-COPD/non-smoker LUAD had higher lepidic pattern percentages, lower necrosis, higher fibrosis, and a lower mutation rate in KRAS and PIK3CA. The same gene mutations were detected in both pathological and normal areas in COPD/smokers and non-COPD/smokers.\"}]","Is There a Link between Chronic Obstructive Pulmonary Disease and Lung Adenocarcinoma? - Clinico-Pathological and Molecular Study | PDF",1790021979,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/799cff3ac5971454ab38272089a1e100.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5e075b526b8172285fcb1698e02a857.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/411fb607f18a9e5bfed9510b8cec102b.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e60bd266d9350e98d35eb42cc5976dd.webp",980,1385]